DarioHealth Corp. — Form 8-K
Filed September 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
DarioHealth filed an 8-K on 2026-09-04 reporting Item 5.02 (departure of directors/officers and compensatory arrangements). The filing header indicates a compensatory arrangement for certain officers was disclosed, but the actual text of the arrangement—including counterparties, dollar amounts, percentages, share counts, vesting terms, or effective dates—is not contained in the accessible portion of this filing extract. The document references only exist as file listings without substantive content disclosure.
Why this rating
Officer compensation is routine disclosure. Absence of specific dollar figures or material terms prevents assessment of materiality relative to $28M market cap.
Extracted items
See more from September 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.